CIK: 0001560009
Total reported value
$141.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GKOS | Glaukos CORP | Stock-Healthcare | 38.17% | — | — | |
| 2 | FPRX | Five Prime Therapeutics INC | Stock-Other | 32.04% | — | — | |
| 3 | OCUL | Ocular Therapeutix INC | Stock-Other | 15.45% | — | — | |
| 4 | CLVSEUR | Clovis Oncology INC | Stock-Other | 5.65% | — | — | |
| 5 | ✓ | Biotie Therapies Oyj | Stock-Other | 5.12% | — | — | |
| 6 | AKAOQ | Achaogen INC | Stock-Other | 2.55% | — | — | |
| 7 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 1.02% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | FPRX | Five Prime Therapeutics INC | +5.5% | — | Unchanged |
| 2 | OCUL | Ocular Therapeutix INC | +3.3% | — | Unchanged |
| 3 | ✓ | Biotie Therapies Oyj | +2.9% | — | Unchanged |
| 4 | CBAYUSD | Cymabay Therapeutics INC | 0% | — | Unchanged |
| 5 | AKAOQ | Achaogen INC | -1.8% | — | Unchanged |
| 6 | CLVSEUR | Clovis Oncology INC | -2.7% | — | Unchanged |
| 7 | GKOS | Glaukos CORP | -7.2% | — | Unchanged |